Cytek Biosciences, Inc. provided earnings guidance for the year ended December 31, 2024. For the period, the company expects total revenue to be in the range of $203 million to $213 million, representing growth of 5% to 10% over the year ended December 31, 2023, assuming no change in currency exchange rates. Also, the company expects to report positive net income.